Dailypharm Live Search Close

[Reporter’s View] Need momentum to boost investments

By Kim, Jin-Gu | translator Kim, Jung-Ju

24.03.11 05:50:13

가나다라 0



Investment in the domestic pharma-bio industry is slowly rising, awakening from its long winter slumber. Although it is still too early to call it a full spring compared to the boom the industry had enjoyed in 2021-2022, however, significant signs of recovery are being shown through various indicators.

Such change is usually most often noted first in the stock market. The KRX Healthcare Index, a leading index for the pharma and biotech sector, has been consistently above 3,000 since the start of the year. This is in contrast to last year when the score remained in the low 2000 range for most of the year. On the 8th, the index reached 3441.04. This is the highest index reached since January 13, 2022, w

Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)